This continuing education activity is designed to enable the learner to understand the challenges of working in oncology and how they can maintain a healthy work-life balance.
Palbociclib (Ibrance®) is an oral therapy for postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.
Panobinostat (Farydak ®) is an oral chemotherapy given in combination with other medications for the treatment of several types of cancers.
Oncology patients may need the care of an Intensive Care Unit (ICU) and this unfamiliar environment can cause a great deal of stress for the oncology patient and/or family.
The first Sunday in June celebrates National Cancer Survivor’s Day. With over 13 million survivors in the US alone, there is a lot to celebrate! Learn more about cancer survivorship, watch the Navigating Life After Cancer webinar or create your own OncoLife Care Plan to celebrate your favorite survivor.
Study shows potential for noninvasive tumor detection
Jun 26, 2015
But more research is needed before test is used for monitoring or screening, researchers say
Jun 25, 2015
Adverse outcomes include anxiety; management type and treatment don't impact outcomes
Jun 25, 2015
Surgery found 100 percent curative, regardless of the time to treatment
Our award winning cancer education content is now available for licensing and syndication.
Please help us to better understand skin cream usage for patients who develop skin redness/irritation during radiation therapy. We are very interested in the opinions and experience of both patients and providers regarding skin cream usage for radiation-related skin reactions. Your participation in this survey would be much appreciated.